|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Villanueva A, Hernandez-Gea V and Llovet
JM: Medical therapies for hepatocellular carcinoma: A critical view
of the evidence. Nat Rev Gastroenterol Hepatol. 10:34–42. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Crocetti L, Bargellini I and Cioni R:
Loco-regional treatment of HCC: Current status. Clin Radiol.
72:626–635. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Matsui O: Current status of hepatocellular
carcinoma treatment in Japan: Transarterial chemoembolization. Clin
Drug Invest. 32 Suppl 2:S3–S13. 2012. View Article : Google Scholar
|
|
5
|
Kidd JG and Rous P: Cancers deriving from
the virus papillomas of wild rabbits under natural conditions. J
Exp Med. 71:469–494. 1940. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ramirez LH, Julièron M, Bonnay M,
Koscielny S, Zhao Z, Gouyette A and Munck JN: Stimulation of tumor
growth in vitro and in vivo by suramin on the VX2 model. Invest New
Drugs. 13:51–53. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Geschwind JF, Artemov D, Abraham S, Omdal
D, Huncharek MS, McGee C, Arepally A, Lambert D, Venbrux AC and
Lund GB: Chemoembolization of liver tumor in a rabbit model:
Assessment of tumor cell death with diffusion weighted MR imaging
and histologic analysis. J Vasc Interv Radiol. 11:1245–1255. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tong H, Li X, Zhang CL, Gao JH, Wen SL,
Huang ZY, Wen FQ, Fu P and Tang CW: Transcatheter arterial
embolization followed by octreotide and celecoxib synergistically
prolongs survival of rabbits with hepatic VX2 allografts. J Dig
Dis. 14:29–37. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guan L: Angiogenesis dependent
characteristics of tumor observed on rabbit VX2 hepatic carcinoma.
Int J Clinical Exp Pathol. 8:12014–12027. 2015.
|
|
10
|
Virmani S, Harris KR, Szolc-Kowalska B,
Paunesku T, Woloschak GE, Lee FT, Lewandowski RJ, Sato KT, Ryu RK,
Salem R, et al: Comparison of two different methods for inoculating
VX2 tumors in rabbit livers and hind limbs. J Vasc Interv Radiol.
19:931–936. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun JH, Zhang YL, Nie CH, Yu XB, Xie HY,
Zhou L and Zheng SS: Considerations for two inoculation methods of
rabbit hepatic tumors: Pathology and image features. Exp Ther Med.
3:386–390. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Parvinian A, Casadaban LC and Gaba RC:
Development, growth, propagation and angiographic utilization of
the rabbit VX2 model of liver cancer: A pictorial primer and ‘how
to’ guide. Diagn Interv Radiol. 20:335–340. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
White SB, Chen J, Gordon AC, Harris KR,
Nicolai JR, West DL and Larson AC: Percutaneous ultrasound guided
implantation of VX2 for creation of a rabbit hepatic tumor model.
PLoS One. 10:e01238882015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tong H, Li X, Zhang CL, Gao JH, Wen SL,
Huang ZY and Tang CW: Octreotide and celecoxib synergistically
encapsulate VX2 hepatic allografts following transcatheter arterial
embolisation. Exp Ther Med. 5:777–782. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen Z, Kang Z, Xiao EH, Tong M, Xiao YD
and Li HB: Comparison of two different laparotomy methods for
modeling rabbit VX2 hepatocarcinoma. World J Gastroenterol.
21:4875–4882. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Osuga K, Maeda N, Higashihara H, Hori S,
Nakazawa T, Tanaka K, Nakamura M, Kishimoto K, Ono Y and Tomiyama
N: Current status of embolic agents for liver tumor embolization.
Int J Clin Oncol. 17:306–315. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lokmic Z and Mitchell GM: Visualisation
and stereological assessment of blood and lymphatic vessels. Histol
Histopathol. 26:781–796. 2011.PubMed/NCBI
|
|
18
|
Bupathi M, Kaseb A, Meric-Bernstam F and
Naing A: Hepatocellular carcinoma: Where there is unmet need. Mol
Oncol. 9:1501–1509. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang W, Lai SL, Chen J, Xie D, Wu FX, Jin
GQ and Su DK: Validated preoperative computed tomography risk
estimation for postoperative hepatocellular carcinoma recurrence.
World J Gastroenterol. 23:6467–6473. 2017. View Article : Google Scholar : PubMed/NCBI
|
